Next Article in Journal
NADA Protocol for Behavioral Health. Putting Tools in the Hands of Behavioral Health Providers: The Case for Auricular Detoxification Specialists
Next Article in Special Issue
Understanding the Pathological Basis of Neurological Diseases Through Diagnostic Platforms Based on Innovations in Biomedical Engineering: New Concepts and Theranostics Perspectives
Previous Article in Journal
Evaluation of the Effectiveness of Acupuncture in the Treatment of Knee Osteoarthritis: A Case Study
Previous Article in Special Issue
Report from the BIT’s 1st Annual World Congress of Biomedical Engineering Held in Xi’an, China, 9–11 November 2017
Article Menu
Issue 1 (March) cover image

Export Article

Open AccessReview
Medicines 2018, 5(1), 19;

Current and Future Applications of Biomedical Engineering for Proteomic Profiling: Predictive Biomarkers in Neuro-Traumatology

Department of Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, ON M5T 2S8, Canada
School of Medicine, University of Cagliari, 09124 Cagliari, Italy
School of Medicine, Aristotle University of Thessaloniki, 54623 Thessaloniki, Greece
National Hospital for Neurology and Neurosurgery, University College London, London WC1N 3BG, UK
Fondazione IRCCS IstitutoNeurologico “Carlo Besta”, 20133 Milano, Italy
Division of Neurosurgery, University of Strasbourg, 67000 Strasbourg, France
Brain and Mind Institute, Physics & Astronomy Department, Western University, London, ON N6A 3K7, Canada
John Radcliffe Hospital, Oxford University, Oxford OX3 9DU, UK
Author to whom correspondence should be addressed.
Received: 31 December 2017 / Revised: 29 January 2018 / Accepted: 30 January 2018 / Published: 5 February 2018
(This article belongs to the Special Issue New Innovations in Biomedical Engineering)
Full-Text   |   PDF [693 KB, uploaded 5 February 2018]   |  


This systematic review aims to summarize the impact of nanotechnology and biomedical engineering in defining clinically meaningful predictive biomarkers in patients with traumatic brain injury (TBI), a critical worldwide health problem with an estimated 10 billion people affected annually worldwide. Data were collected through a review of the existing English literature performed on Scopus, MEDLINE, MEDLINE in Process, EMBASE, and/or Cochrane Central Register of Controlled Trials. Only experimental articles revolving around the management of TBI, in which the role of new devices based on innovative discoveries coming from the field of nanotechnology and biomedical engineering were highlighted, have been included and analyzed in this study. Based on theresults gathered from this research on innovative methods for genomics, epigenomics, and proteomics, their future application in this field seems promising. Despite the outstanding technical challenges of identifying reliable biosignatures for TBI and the mixed nature of studies herein described (single cells proteomics, biofilms, sensors, etc.), the clinical implementation of those discoveries will allow us to gain confidence in the use of advanced neuromonitoring modalities with a potential dramatic improvement in the management of those patients. View Full-Text
Keywords: traumatic brain injury; biomarkers; proteomics; microRNA; mass spectroscopy traumatic brain injury; biomarkers; proteomics; microRNA; mass spectroscopy

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Ganau, M.; Syrmos, N.; Paris, M.; Ganau, L.; Ligarotti, G.K.; Moghaddamjou, A.; Chibbaro, S.; Soddu, A.; Ambu, R.; Prisco, L. Current and Future Applications of Biomedical Engineering for Proteomic Profiling: Predictive Biomarkers in Neuro-Traumatology. Medicines 2018, 5, 19.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Medicines EISSN 2305-6320 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top